Drugs / SFP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01503021 | Nov 2011 → Jan 2014 | end stage renal failure | Rockwell Medical Technologies, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SFP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01503021 ↗ |
| Route | Other | “administered via the liquid bicarbonate concentrate” NCT01503021 ↗ |